BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen C, Liu J, Wang J, Zhong X, Dong D, Yang X, Wang Y. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. Int Immunopharmacol 2020;81:106274. [PMID: 32044664 DOI: 10.1016/j.intimp.2020.106274] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Q, Zhang F, Feng D, Li D, Xia Y, Gan M. An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma. Front Genet 2022;13:866696. [DOI: 10.3389/fgene.2022.866696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wang Q, Tang H, Luo X, Chen J, Zhang X, Li X, Li Y, Chen Y, Xu Y, Han S. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma. Front Immunol 2022;13:890150. [PMID: 35686121 DOI: 10.3389/fimmu.2022.890150] [Reference Citation Analysis]
3 Adams AC, Borden ES, Macy AM, Thomson N, Cui H, Gimbel MI, Wilson MA, Buetow KH, Roe DJ, DiCaudo DJ, Homsi J, Hastings KT. High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers (Basel) 2022;14:2200. [PMID: 35565329 DOI: 10.3390/cancers14092200] [Reference Citation Analysis]
4 Zhang Y, Zhang Z, Zhang W, Hu H, Bao G. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification. Dis Markers 2021;2021:7694239. [PMID: 34868397 DOI: 10.1155/2021/7694239] [Reference Citation Analysis]
5 Peng Z, Liu XY, Cheng Z, Kai W, Song Z. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes. Ann Transl Med 2021;9:1576. [PMID: 34790782 DOI: 10.21037/atm-21-4756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chen S, Huang L, Zhou S, Zhang Q, Ruan M, Fu L, Yang B, Xu D, Mei C, Mao Z. NS398 as a potential drug for autosomal-dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models. J Cell Mol Med 2021;25:9597-608. [PMID: 34551202 DOI: 10.1111/jcmm.16903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sousa LM, Almeida JS, Fortes-Andrade T, Santos-Rosa M, Freitas-Tavares P, Casanova JM, Rodrigues-Santos P. Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers (Basel) 2021;13:3885. [PMID: 34359785 DOI: 10.3390/cancers13153885] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Zhang Z, Li Q, Wang F, Ma B, Meng Y, Zhang Q. Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma. Front Genet 2021;12:606816. [PMID: 34194463 DOI: 10.3389/fgene.2021.606816] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Guo H, Li Y, Liu Y, Chen L, Gao Z, Zhang L, Zhou N, Guo H, Shi B. Prognostic Role of the Ubiquitin Proteasome System in Clear Cell Renal Cell Carcinoma: A Bioinformatic Perspective. J Cancer 2021;12:4134-47. [PMID: 34093816 DOI: 10.7150/jca.53760] [Reference Citation Analysis]
10 Apanovich N, Apanovich P, Mansorunov D, Kuzevanova A, Matveev V, Karpukhin A. The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer. Front Oncol 2021;11:615787. [PMID: 34046336 DOI: 10.3389/fonc.2021.615787] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Fang R, Iqbal M, Chen L, Liao J, Luo J, Wei F, Wen W, Sun W. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Aging (Albany NY) 2021;13:11507-27. [PMID: 33867351 DOI: 10.18632/aging.202842] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Zhan C, Wang Z, Xu C, Huang X, Su J, Chen B, Wang M, Qi Z, Bai P. Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma. Front Mol Biosci 2021;8:609865. [PMID: 33968978 DOI: 10.3389/fmolb.2021.609865] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Liao Z, Yao H, Wei J, Feng Z, Chen W, Luo J, Chen X. Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma. Transl Androl Urol 2021;10:1607-19. [PMID: 33968649 DOI: 10.21037/tau-20-1348] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Peng Q, Shen Y, Fu K, Dai Z, Jin L, Yang D, Zhu J. Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system. Aging (Albany NY) 2021;13:7361-81. [PMID: 33686949 DOI: 10.18632/aging.202594] [Reference Citation Analysis]
15 Shen C, Liu J, Yang X, Jiao W, Wang Y. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Front Endocrinol (Lausanne) 2021;12:568397. [PMID: 33692753 DOI: 10.3389/fendo.2021.568397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Song LB, Luan JC, Zhang QJ, Chen L, Wang HY, Cao XC, Song NH, Lu Y. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma. J Immunol Res 2021;2021:6686284. [PMID: 33688507 DOI: 10.1155/2021/6686284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lu W, Che X, Qu X, Zheng C, Yang X, Bao B, Li Z, Wang D, Jin Y, Wang Y, Xiao J, Qi J, Liu Y. Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation. Front Cell Dev Biol 2021;9:622198. [PMID: 33681201 DOI: 10.3389/fcell.2021.622198] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Xu X, Lu Y, Wu Y, Wang M, Wang X, Wang H, Chen B, Li Y. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients. Cancer Cell Int 2021;21:117. [PMID: 33602220 DOI: 10.1186/s12935-021-01823-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Shen R, Liu B, Li X, Yu T, Xu K, Ma J. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. BMC Cancer 2021;21:144. [PMID: 33557781 DOI: 10.1186/s12885-021-07852-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shen C, Wang L, Yang X, Liu J, Yang Q, Ding X, Niu H, Wang Y. Construction of a immune-associated genes based prognostic signature in bladder cancer. Artif Cells Nanomed Biotechnol 2021;49:108-19. [PMID: 33459039 DOI: 10.1080/21691401.2020.1865994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shen C, Xu T, Sun Y, Wang L, Liang Z, Niu H, Jiao W, Wang Y. Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer. Dis Markers 2020;2020:8866730. [PMID: 33456631 DOI: 10.1155/2020/8866730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yiqi Z, Ziyun L, Qin F, Xingli W, Liyu Y. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts. Technol Cancer Res Treat 2020;19:1533033820980769. [PMID: 33308057 DOI: 10.1177/1533033820980769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
23 Han W, Xu X, Che K, Ma G, Li D, Zhang M, Jiao W, Niu H. Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma. Dis Markers 2020;2020:8841859. [PMID: 33224313 DOI: 10.1155/2020/8841859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Shen C, Liu J, Wang L, Liang Z, Niu H, Wang Y. Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer. Cancer Cell Int 2020;20:538. [PMID: 33292266 DOI: 10.1186/s12935-020-01627-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Qian S, Sun S, Zhang L, Tian S, Xu K, Zhang G, Chen M. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC. Front Oncol 2020;10:556018. [PMID: 33134164 DOI: 10.3389/fonc.2020.556018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li JP, Li R, Liu X, Huo C, Liu TT, Yao J, Qu YQ. A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma. Front Oncol 2020;10:560779. [PMID: 33163400 DOI: 10.3389/fonc.2020.560779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
27 Hu C, Chen B, Huang Z, Liu C, Ye L, Wang C, Tong Y, Yang J, Zhao C. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients. J Transl Med 2020;18:337. [PMID: 32873319 DOI: 10.1186/s12967-020-02512-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wu Z, Ouyang C, Peng L. An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma. Medicine (Baltimore) 2020;99:e21693. [PMID: 32846785 DOI: 10.1097/MD.0000000000021693] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Li M, Wang H, Li W, Peng Y, Xu F, Shang J, Dong S, Bu L, Wang H, Wei W, Hu Q, Liu L, Zhao Q. Identification and validation of an immune prognostic signature in colorectal cancer. Int Immunopharmacol 2020;88:106868. [PMID: 32771948 DOI: 10.1016/j.intimp.2020.106868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
30 Wang L, Wei Q, Zhang M, Chen L, Li Z, Zhou C, He M, Wei M, Zhao L. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients. Int Immunopharmacol 2020;87:106795. [PMID: 32707495 DOI: 10.1016/j.intimp.2020.106795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
31 Gao X, Yang J, Chen Y. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma. J Cell Physiol 2020;235:9834-50. [PMID: 32452055 DOI: 10.1002/jcp.29796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
32 Shen C, Liu J, Wang J, Yang X, Niu H, Wang Y. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA. Dis Markers 2020;2020:4312629. [PMID: 32454905 DOI: 10.1155/2020/4312629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Yang H, Han M, Li H. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients. Front Oncol 2020;10:707. [PMID: 32432045 DOI: 10.3389/fonc.2020.00707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
34 Guo D, Wang M, Shen Z, Zhu J. A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. J Transl Med 2020;18:123. [PMID: 32143735 DOI: 10.1186/s12967-020-02286-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]